Cooperative stimulation of vascular endothelial growth factor expression by hypoxia and reactive oxygen species: the effect of targeting vascular endothelial growth factor and oxidative stress in an orthotopic xenograft model of bladder carcinoma

@article{Brown2005CooperativeSO,
  title={Cooperative stimulation of vascular endothelial growth factor expression by hypoxia and reactive oxygen species: the effect of targeting vascular endothelial growth factor and oxidative stress in an orthotopic xenograft model of bladder carcinoma},
  author={N S Brown and Edward H Streeter and A Jones and Adrian L. Harris and Roy Bicknell},
  journal={British Journal of Cancer},
  year={2005},
  volume={92},
  pages={1696 - 1701}
}
Elevated thymidine phosphorylase has been shown to correlate with increased angiogenesis and poor prognosis in many cancers including transitional cell carcinoma of the bladder. In vitro studies have demonstrated that thymidine phosphorylase activity causes cellular oxidative stress and increases secretion of vascular endothelial growth factor. In this study, we show that thymidine phosphorylase activity also augments levels of the hypoxia-inducible factor-1α during in vitro hypoxia, and that… Expand
Hypertonic Stress Induces VEGF Production in Human Colon Cancer Cell Line Caco-2: Inhibitory Role of Autocrine PGE2
TLDR
Investigation of the effect of exposure to a hypertonic medium, to emulate colonic environment, on VEGF production by colon cancer cells indicated that hypertonicity stimulates V EGF production in colon cancer cell lines. Expand
Nucleosides, Nucleotides and Nucleic Acids
Taylor & Francis makes every effort to ensure the accuracy of all the information (the “Content”) contained in the publications on our platform. However, Taylor & Francis, our agents, and ourExpand
The Role of Platelet-Derived Endothelial Cell Growth Factor/Thymidine Phosphorylase in Tumor Behavior
TLDR
The various complex interactions of TP give it an essential role in cellular functioning and, hence, it is an ideal target in cancer therapy. Expand
Antibody Targeting of Cathepsin S Inhibits Angiogenesis and Synergistically Enhances Anti-VEGF
TLDR
Data demonstrates that the antibody-mediated targeting of cathepsin S represents a novel method of inhibiting angiogenesis and has the potential to significantly enhance current treatments of tumour neovascularisation and may also be of use in the treatment of other conditions associated with inappropriate angiogenic conditions. Expand
Hypoxia and free radicals: role in tumor progression and the use of engineering-based platforms to address these relationships.
TLDR
An improved understanding of the mechanisms responsible for the hypoxia/ROS/HIF-1α axis in tumor progression will yield the development of better targeted therapies, and opportunities whereby engineering techniques may be employed to better understand the physical and biochemical factors controlling ROS expression are discussed. Expand
Targeting platelet-derived endothelial cell growth factor/thymidine phosphorylase for cancer therapy.
TLDR
This review will focus on the different biological activities of PD-ECGF/TP and their implications for cancer progression and treatment. Expand
The dual role of thymidine phosphorylase in cancer development and chemotherapy
TLDR
Clinical trials that combine cape citabine with TP‐inducing therapies (such as taxanes or radiotherapy) suggest that increasing TP expression is an adequate strategy to enhance the antitumoral efficacy of capecitabine. Expand
Angiogenic Signaling and Structural Abnormalities in Tumors
TLDR
Besides tumor cells, also other cellular components of tumor microenvironment play an important role in stimulation of endothelium, out of which the key players are different populations of bone marrow-derived cells of myeloid origin. Expand
Mechanisms of Disease: angiogenesis in urologic malignancies
TLDR
The literature on studies of angiogenesis pathways and markers for renal cancer, prostate cancer and bladder cancer is reviewed to demonstrate the importance of these pathways and the need to develop selection criteria for patients who are candidates for antiangiogenic therapies. Expand
No relationship between thymidine phosphorylase (TP, PD-ECGF) expression and hypoxia in carcinoma of the cervix
TLDR
In 119 patients with locally advanced cervical carcinoma who underwent radiotherapy, the presence of TP expression predicted for disease-specific and metastasis-free survival and has weak prognostic power. Expand
...
1
2
3
...

References

SHOWING 1-10 OF 27 REFERENCES
Vanadate-induced Expression of Hypoxia-inducible Factor 1α and Vascular Endothelial Growth Factor through Phosphatidylinositol 3-Kinase/Akt Pathway and Reactive Oxygen Species*
TLDR
The results suggest that the expression of HIF-1 and VEGF induced by vanadate through PI3K/Akt may be an important signaling pathway in theVanadate-induced carcinogenesis, and ROS may play an important role. Expand
Prevention of hypoxia-induced apoptosis by the angiogenic factor thymidine phosphorylase.
TLDR
It is suggested that TP can confer resistance to apoptosis induced by hypoxia and the degradation products of thymidine are involved in this resistance. Expand
Interferon gamma-dependent induction of thymidine phosphorylase/platelet-derived endothelial growth factor through gamma-activated sequence-like element in human macrophages.
TLDR
It is observed that IFN-gamma most effectively increased the expression of TP in cultured human monocytic U937 cells and could be a mediator of TP expression in infiltrated monocyte/macrophages, and those monocyte or macrophages expressing TP might play an important role in malignancy and angiogenesis in various human tumors. Expand
Expression of the angiogenic factor thymidine phosphorylase/platelet-derived endothelial cell growth factor in primary bladder cancers.
TLDR
TP protein is expressed in bladder cancers, and expression is associated with an aggressive phenotype, which provides a potential therapeutic target in bladder cancer. Expand
Vascular endothelial growth factor is a predictor of relapse and stage progression in superficial bladder cancer.
TLDR
It is shown that VEGF can predict the behavior of superficial bladder tumors and is a therapeutic target for intravesical therapy, indicating that seeding via angiogenesis may be a major mechanism in the pathogenesis of recurrence. Expand
Thymidine phosphorylase induces carcinoma cell oxidative stress and promotes secretion of angiogenic factors.
TLDR
It is shown that thymidine induces oxidative stress in TP-overexpressing carcinoma cells, promoting secretion of the stress-induced angiogenic factors vascular endothelial growth factor and interleukin-8, and inducing matrix metalloproteinase-1. Expand
The effect of a thymidine phosphorylase inhibitor on angiogenesis and apoptosis in tumors.
TLDR
It is suggested that the expression of TP plays an important role in tumor growth and that TPI suppresses tumor growth by increasing the proportion of apoptotic cells and probably inhibiting angiogenesis. Expand
Role of thymidine phosphorylase in an in vitro model of human bladder cancer invasion.
TLDR
The apparent advantage of thymidine phosphorylase expression to tumor cells can be exploited by therapies that utilize prodrugs such as 5-deoxy-5-fluorouridine, which is activated by thymazine phosphoryLase and inhibited invasion in the authors' model. Expand
Molecular basis for the inhibition of hypoxia-induced apoptosis by 2-deoxy-D-ribose.
TLDR
2-Deoxy-L-ribose and its analogs may enhance apoptosis and suppress the growth of tumors by competitively inhibiting the activities of 2-deoxy-d-riboses and thus these analogs show promise for anti-tumor therapy. Expand
Induction of Hypoxia-inducible Factor-1α by Transcriptional and Translational Mechanisms*
TLDR
It is established that the non-hypoxic induction of the Hif-1 transcription factor via vasoactive hormones (Ang II and thrombin) is triggered by a dual mechanism,i.e. a PKC-mediated transcriptional action and a ROS-dependent increase in HIF-1α protein expression. Expand
...
1
2
3
...